Sex hormone-dependent and -independent regulation of serum BAFF and TNF in cohorts of transgender and cisgender men and women

Sex hormone-dependent and -independent regulation of serum BAFF and TNF in cohorts of transgender and cisgender men and women

Background: The risk of inflammatory diseases is sex-dependent, but it rema ins unknown whether this is due to the impact of sex hormones or sex chromo somes. Transgender individuals represent a unique cohort for studying the relative influence of endocrine and chromosomal factors. Here we compar...

Full description

Bibliographic Details
Main Authors:	Christos Tsatsanis, Angel Elenkov, Irene Leijonhufvud, Katerina Vaporidi, Åsa Tivesten, Aleksander Giwercman
Format:	Article
Language:	English
Published:	Bioscientifica 2023-02-01
Series:	Endocrine Connections
Subjects:	tnf baff gender immunology inflammation
Online Access:	https://ec.bioscientifica.com/view/journals/ec/12/3/EC-22-0456.xml

Similar Items

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2022-09-01)

The BAFF-APRIL System in Cancer
by: Md Ashik Ullah, et al.
Published: (2023-03-01)

BAFF and BAFF-Receptor in B Cell Selection and Survival
by: Cristian R. Smulski, et al.
Published: (2018-10-01)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018-09-01)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018-09-01)

Association of BAFF and BAFF-R polymorphisms with sarcoidosis in a Greek patient cohort
by: Maria Martinou, et al.
Published: (2022-10-01)

BAFF blockade in experimental autoimmune encephalomyelitis reduces inflammation in the meninges and synaptic and neuronal loss in adjacent brain regions
by: Kanak Gupta, et al.
Published: (2023-10-01)

IL-35, TNF-α, BAFF, and VEGF serum levels in patients with different rheumatic diseases
by: Piotr Wojdasiewicz, et al.
Published: (2019-06-01)

Pleiotropic effects of BAFF on the senescence-associated secretome and growth arrest
by: Martina Rossi, et al.
Published: (2023-04-01)

The impact of Epstein‐Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptors
by: Kevin Madayag, et al.
Published: (2022-11-01)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
by: Hui Deng, et al.
Published: (2019-10-01)

Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients
by: Yongjian Chen, et al.
Published: (2020-05-01)

B-cell activating factor (BAFF) — a new factor linking immunity to diet?
by: Bienertova-Vasku Julie, et al.
Published: (2012-06-01)

The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory
by: Jodi eKarnell, et al.
Published: (2012-01-01)

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
by: Lucas L. van den Hoogen, et al.
Published: (2022-12-01)

Evolutionarily Selected Overexpression of the Cytokine BAFF Enhances Mucosal Immune Response Against P. falciparum
by: Valeria Lodde, et al.
Published: (2020-10-01)

BAFF induces CXCR5 expression during B cell differentiation in bone marrow
by: Hajime Koizumi, et al.
Published: (2023-07-01)

Bioinformatic Prediction of miRNAs Targeting APRIL and BAFF Genes in Chronic Lymphocytic Leukemia
by: Mahdieh Mondanizadeh, et al.
Published: (2019-11-01)

Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves’ disease
by: Xin Wang, et al.
Published: (2021-04-01)

Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics
by: Jenny Hu, et al.
Published: (2014-02-01)

Subclinical Atherosclerosis Is Associated with Discrepancies in BAFF and APRIL Levels and Altered Breg Potential of Precursor-like Marginal Zone B-Cells in Long-Term HIV Treated Individuals
by: Matheus Aranguren, et al.
Published: (2022-12-01)

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
by: Maria Antonella Zingaropoli, et al.
Published: (2023-04-01)

B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)
by: Adam Klocperk, et al.
Published: (2023-10-01)

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome
by: Christina-Maria Flessa, et al.
Published: (2022-03-01)

B Cell Activating Factor (BAFF) Is Required for the Development of Intra-Renal Tertiary Lymphoid Organs in Experimental Kidney Transplantation in Rats
by: Louisa Steines, et al.
Published: (2020-10-01)

Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection
by: Kim Doyon-Laliberté, et al.
Published: (2022-12-01)

Serum B cell activating factor (BAFF) as a biomarker for induction of remission with rituximab in ANCA-associated vasculitis
by: Kazuyuki Tsuboi, et al.
Published: (2022-10-01)

Non-canonical NF-κB signalling initiated by BAFF influences B cell biology at multiple junctures
by: Sandra eGardam, et al.
Published: (2014-01-01)

Analysis of lncRNA and mRNA Repertoires in Lung From BAFF-R-Deficient Pneumocystis-Infected Mice
by: Heng-Mo Rong, et al.
Published: (2022-06-01)

Impact of BAFF Blockade on Inflammation, Germinal Center Reaction and Effector B-Cells During Acute SIV Infection
by: Gwenoline Borhis, et al.
Published: (2020-02-01)

BAFF promotes regulatory T-cell apoptosis and blocks cytokine production by activating B cells in primary biliary cirrhosis
by: Bo Zhang, et al.
Published: (2013-05-01)

Therapeutic potential of hydroxychloroquine on serum B-cell activating factor belonging to the tumor necrosis factor family (BAFF) in rheumatoid arthritis patients
by: Amina A. Mahdy, et al.
Published: (2014-06-01)

Evaluating the Link between BAFF System Gene Expression and Acute Rejection Development in Kidney Transplantation
by: Rafael Alfaro, et al.
Published: (2022-07-01)

Treatment-Induced BAFF Expression and B Cell Biology in Multiple Sclerosis
by: Ide Smets, et al.
Published: (2021-05-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS
by: E. V. Suponitskya, et al.
Published: (2014-10-01)

B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease
by: Daniela Giordano, et al.
Published: (2023-02-01)

Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers
by: David Aguirre-Valencia, et al.
Published: (2020-01-01)